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FragileXmental retardationprotein (FMRP), the protein respon-
sible for the fragileX syndrome, is anRNA-bindingprotein involved
in localization and translation of neuronal mRNAs. One of the
RNAs known to interact with FMRP is the dendritic non-translat-
able brain cytoplasmic RNA 1 BC1 RNA that works as an adaptor
molecule linking FMRP and some of its regulatedmRNAs. Here, we
showed that theN terminus of FMRPbinds strongly and specifically
to BC1 and to its potential human analog BC200. This region does
not contain a motif known to specifically recognize RNA and thus
constitutes a new RNA-binding motif. We further demonstrated
that FMRP recognition involves the 5 stem loop of BC1 and that
this is the region that exhibits complementarity to FMRP target
mRNAs, raising the possibility that FMRPplays a direct role inBC1/
mRNA annealing.
The fragile X mental retardation protein (FMRP)3 is the protein
involved in the fragile X syndrome, themost common cause of inherited
mental retardation. FMRP is highly expressed in neurons, where it is
involved inmRNP transport and translation, two processes required for
synaptic plasticity (1, 2). Thus, FMRP acts as a translational repressor
both in vitro and in vivo (3–8), and its effect is more pronounced at the
synapses (7). The specificmechanism(s) throughwhich FMRP regulates
translation still remains to be understood; in particular, it is not clear
whether the regulation occurs at the level of translation initiation (3),
during the translation elongation phase (according to a “stalling poly-
somes” hypothesis) (8, 9), or both, depending on the different stages of
development. With respect to mRNP transport, FMRP has both a
nuclear localization signal (NLS) and a nuclear export signal (NES) and
is capable of shuttling between the nucleus and the cytoplasm (10); it
therefore seems likely that FMRP accompanies specific mRNAs from
the nucleus to the cytoplasm. Furthermore, granules containing FMRP
are transported to locations throughout the dendrite, where translation is
regulated by synaptic activation (11), reminiscent of the granules in which
mRNPs are thought to be transported. Indeed,mass spectrometric analysis
of RNase-sensitivemRNP transport granules also identified, among several
proteins involved in transport along the cytoskeleton, FMRP (12).
As a protein involved in mRNP transport and regulation of transla-
tion, FMRP is expected to bind selectively to a subset of the mRNAs.
Quite a variety of mRNAs have been identified in vitro and in vivo as
potential targets of the entire FMRP (13–16), and it is still not clear how
the mRNAs are recognized. There are at least three RNA elements that
can direct FMRP binding (for a recent review, see Ref. 17). The first is a
G-rich RNA structure called the G quartet (14, 18, 19), and the second
consists of U-rich stretches (16). Thirdly, we have demonstrated that
FMRP binds specifically to the non-coding RNA BC1, which in turn
exhibits significant complementarity to and anneals with somemRNAs
regulated by FMRP (7). BC1 is a non-translatable RNA, specific of
rodents, that acts as an adapter molecule determining the selectivity of
FMRP for some of its target mRNAs. Consistent with a role of the
BC1-FMRP complex(es) in translational inhibition, BC1 has also been
shown to inhibit the in vitro formation of the 48 S preinitiation complex
and to bind two key proteins involved in regulation of translation, the
poly(A)-binding protein and the translational initiation factor eIF4A
(20, 21). Finally, recent findings suggest that FMRP may associate with
microRNAs and with components of the RNA-induced silencing com-
plex (22–24). microRNAs are small non-coding RNAmolecules (22–24
nt long) that base pair with mRNAs and either direct their degradation
or direct their translational regulation (25). In this way,microRNAsmay
attract FMRP to specific mRNAs, similar to BC1.
FMRP contains three sequencemotifs that are characteristic of RNA-
binding domains, namely two copies of the KH motif and an RGG box
(26). In addition, the N-terminal 217 amino acids can also bind to RNA
homopolymers (27, 28). Of these four domains, only the RGG box has
been demonstrated to bind RNAwith sequence or structure specificity;
it recognizes the above mentioned G quartet (14, 18). The presence of
multiple RNA-binding domains on the FMRP protein leaves open the
interesting possibility that the competing models on the recognition of
RNAbyFMRP, i.e. viaGquartets, viaU-rich elements, or viaRNAadapters
such as BC1, are actually compatible with each other. To investigate this
possibility, we set out to map the FMRP domain that is responsible for
binding to the BC1 RNA.We showed here that the N-terminal domain of
FMRP binds BC1 RNA in a specific manner and that the BC1 region
responsible for FMRPbinding is foundwithin the stem loop responsible for
mRNAtarget recognition (7).Moreover,we showed that theBC1 analog in
primates, calledBC200 (29), binds directly and specifically to FMRP via the
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same N-terminal domain, strengthening the idea that the two BC RNAs
have the same functional significance in neuronal cells. These results dem-
onstrated that the N terminus, which contains two Tudor motifs of
unknown function, is capable of sequence-specific RNA binding. We dis-
cuss the possibility that theTudormotif actually indicates the presence of a
nucleic acid-binding domain. Furthermore, the N terminus is well sepa-
rated, in sequence and space, from the RGG box that recognizes the
mRNAs via the G quartet, lending support to the idea that FMRP might
recognize its targetmRNAs indifferentways,which eithermaybe linked to
the different functions of the protein or may occur simultaneously and
cooperatively to strengthen the binding.
EXPERIMENTAL PROCEDURES
FMRP Recombinant Proteins—The FMRP constructs used for this
study are: FMRP N terminus (amino acids 1–217), NDF (amino acids
1–134), NDF/NLS (amino acids 1–180), FMRP-KH1 (amino acids 205–
280), FMRP-KH2 (amino acids 281–422), and FMRP C terminus
(amino acids 516–632); they were produced as described previously
(27). The purity of the recombinant proteins was checked by SDS-
PAGE after each step of purification and by mass spectrometry of the
final product. To probe the secondary and tertiary structure of the con-
structs, circular dichroism spectra and nuclear magnetic resonance
experiments were performed as described previously (28).
Human FMRP was produced in baculovirus-infected Sf21 cells using
a His-TAT-tagged full-length FMR1 clone. The recombinant protein
was purified as described previously (30).
PreparationofBC1andBC200DNATemplateandRNATranscripts—DraI
linearizedplasmidspBCX607containing theBC1sequence (31) (agift fromH.
Tiedge) and pPBC200 containing the BC200 sequence (32) (a gift from J.
Brosius) were used as a template for the T7 RNA polymerase to produce
32P-labeled RNAs (BC1 or BC200) in the presence of 50 Ci of [-32P]UTP
(Amersham Biosciences; 3000 Ci/mmol) or non-radioactive RNAs (BC1,
BC200 orBC1 fragments) using an in vitro transcription kit (Ambion).
Templates for the containing portions of BC1 RNA (1–5) were
generated as described below. The entire 5 stem loop (1 deletion
mutant; nt 1–76) was generated by PCR using the primers 5-TAA
TAC GAC TCA CTA TAG GGG TTG GGG ATT TAG CTC-3 and
5-CCAGAGCTGAGGACCGAA-3 and the plasmid pBCX607 as
template. The partial BC1 RNAs corresponding to 3 stem loop (2
deletion mutant; nt 127–152) was amplified by PCR using the prim-
ers T7 and 5-AAA GGT TGT GTG TGC-3, and as template, the
oligonucleotide 5-TAATACGACTCACTATAGAACAAGGTA
ACT GGC ACA CAC AAC CTT T-3. The construct containing the
A stretch (3 deletion mutant; nt 61–138) was amplified using the
primers 5-TAA TAC GAC TCA CTA TAC GGT CCT CAG CTC
TGG-3 and 5-CCA GTT ACC TTG TTT-3 and the plasmid
pBCX607 as template. BC1 5 end lacking the distal one-third of the
stem loop (nt 26–49) (4 construct; nt 1–25/50–76) was generated
by PCR using the same primers used for the 1 construct, and as
template, the oligonucleotide 5-TAA TAC GAC TCA CTA TAG
GGG TTG GGG ATT TAG CTC AGT GGT TTC GGC CCT GGG
TTC GGT CCT CAG CTC TGG-3. The fragment of BC1 5 end
lacking the two-thirds distal (nt 15–60) of the stem loop (5 con-
struct; nt 1–14/61–76) was generated by PCR using the primers T7
and 5-CCA GAG CTG AGG ACC GAA-3, and as template, the
oligonucleotide 5-TAA TAC GAC TCA CTA TAG GGG TTG
GGG ATT TCG GTC CTC AGC TCT GG-3. Amplification was
performed with Pfu polymerase (Stratagene), and the generated PCR
fragments were sequenced before usage. The PCR products were
in vitro-transcribed with T7 RNA polymerase as described above.
Band Shift Experiments—RNA band-shift experiments were per-
formed under variable conditions of stringency and presence of differ-
ent competitors. As a standard BC-FMRP interaction assay, 32P-labeled
BC1 orBC200RNA (1 105 cpm, 0.02 pmol), prepared by transcription
in vitro, was incubated with 400 ng of purified FMRP constructs in the
following binding buffer: 150 or 300 mM KCl, 5 mMMgCl2, 2 mM dithi-
othreitol, 5% glycerol, 20 mM HEPES/KOH, pH 7.6, and 500 ng of total
yeast tRNA or 20 g of heparin. Interaction was performed at room
temperature (25 °C) or on ice for 20 min. The free RNAs and RNA
protein complexes were subsequently separated by electrophoresis on 5
and/or 7% native acrylamide gels in 0.5 Tris-borate-EDTA buffer at
4 °C and then analyzed by autoradiography. In competition experi-
ments, unlabeled RNAs (tRNA, full-length BC1, or BC1 fragments) in
10-, 50-, or 100-fold excess (0.2, 1, or 2 pmol) were added 20 min before
the binding reaction. To map the minimal BC1 region responsible for
the binding, BC1 deletion mutants (corresponding to 3 stem loop (nt
127–152) and the A stretch (nt 61–143) amplified by PCR) were added
in 50- or 100-fold excess before the binding reaction.
Determination of Dissociation Constant (Kd) by Electrophoretic
Mobility Shift Assay—For determination of the apparent binding con-
stant, the same amount of BC1 (or BC200) RNA (1  105 cpm, 0.02
pmol) was incubated with increasing concentrations of protein. Follow-
ing electrophoresis, the radioactive gel was dried and analyzed using a
PhosphorImager and ImageQuant software (AmershamBiosciences) to
quantify the amount of free RNA and RNA-protein complex for each
protein concentration considered. In the assays described here, a great
excess of protein over RNA was employed, and the concentration of
free protein does not appreciably change upon complex formation
([FMRP]free [FMRP]tot). The equation Kdapp ([BC]free[FMRP]free)/
[FMRP-BC] can therefore be simplified to Kdapp ([BC]free/[BC]bound)
[FMRP]tot. Under this condition, the Kdapp is the concentration of
FMRP at which half-of the RNA is bound ([BC]free [BC]bound).
UVCross-linking of in Vitro Reconstituted BC1 RNA-FMRP Complex—
150 fmol of [32P]pCp-labeled neuronal BC1 RNA (0.01mCi/pmol), pre-
pared by transcription in vitro, was incubated on ice for 10min with 1.5,
3.0, 7.5, 15, 30 or 75 pmol of recombinant fragile X mental retardation
protein FMRPN terminus (aa 1–217) in a final volume of 20l of buffer
A (20 mM Hepes/KOH, pH 7.9, 160 mM NaCl, 5 mM MgCl2, 2 mM
dithiothreitol). For competition experiments, 150 fmol of the same
RNA was incubated on ice for 10 min in the presence of 75 pmol of
FMRP and 1.5, 3.0, 7.5, 15, or 30 pmol of non-labeled neuronal BC1
RNA or in vitro-transcribed human U1 snRNA.
UV cross-linking of the BC1 RNA-FMRP complex prepared by
reconstitution in vitro was performed exactly according to a previously
describedmethod (33). 20l of SDS-PAGE loading buffer was added to
each sample. The samples were analyzed on a 10% SDS-polyacrylamide
gel and subsequently visualized by autoradiography.
RESULTS
BC1 RNA Binds FMRP Specifically—The small dendritic brain cyto-
plasmicRNA1 (BC1) is part of the FMRPcomplex in neurons of rodents
and binds directly and specifically to FMRP in vitro (7). To better under-
stand the specificity of the FMRP-BC1 interaction, electrophoretic
mobility shift assays (EMSA)were performed using in vitro-transcribed,
32P-labeled BC1 RNA and recombinant human FMRP protein (Fig. 1A).
Incubation of FMRPwithBC1 leads to the formation of a slowermigrat-
ing complex (lane 2), which can be competed by a 50-fold excess of
unlabeled BC1 RNA (BC1c competitor) but not by a nonspecific com-
petitor like total yeast tRNA tested at the same molar excess (tRNAc
competitor) (Fig. 1A, compare lane 3 with lane 4). Moreover, we have
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previously shown that this complex can also be super shifted by anti-
bodies specific for FMRP (7).
A similar experiment was performed with bovine serum albumin and
twodifferentRNA-bindingproteins, themicrobial transcription and trans-
lation modulator NusG (34) and the spliceosomal 15.5KD/hSnu13p pro-
tein (35), respectively.Neitherof theseproteins formedacomplexwithBC1
(lanes 5–7), showing that BC1 RNA does not bind to any RNA-binding
protein and pointing out the specificity of the FMRP-BC1 interaction.
Titration of FMRP indicates a half-saturation point for BC1 binding
of200 nM (Fig. 1, B and C). An apparent Kd of 200 nM would be in the
range ofKd values observed for other specific RNA-protein interactions.
The true Kd is probably lower, and the FMRP-BC1 binding is even
stronger; the recombinant full-length FMRP protein tends to aggregate,
which is evidenced by the signal seen in the wells of the EMSA gels.
Therefore, the available concentration of FMRP in each lane was cer-
tainly lower than indicated.
The Entire and Structured N-terminal Domain of FMRP Binds
Specifically to BC1 and BC200 RNAs—To map the minimal BC1-
binding domain, we tested a series of FMRP deletion constructs for
BC1 binding activity. We produced a number of FMRP constructs on
the basis of the structural properties of the protein (Fig. 2A); the
domain boundaries were designed according to our previous work in
which the fold of each construct had been checked by circular
dichroism and nuclear magnetic resonance (27). We prepared six
constructs spanning the sequences of the isolated FMRP N terminus
(NT, aa 1–217), of the two KH motifs (KH1, aa 205–280; KH2, aa
281–422), and of the C terminus (CT, aa 516–632; Fig. 2A). NT is
known to comprise three motifs: the well folded N terminal domain
of FMRP, NDF, (aa 1–134), the putative nuclear localization signal,
NLS, (aa 135–180), and a putative helix-turn-helix motif (aa 181–
217), ref28. Of the two KH domains, the first is known to be properly
folded, whereas KH2, possibly due to the absence of interactions
with regions not directly flanking the motif, is unstructured. CT
contains long low complexity stretches and is not folded in a stable
three-dimensional structure in the absence of RNA (Fig. 2A).
To map which of these FMRP domains is responsible for binding to
BC1 RNA, we performed EMSA experiments, incubating each domain
with BC1RNA (Fig. 2B). OnlyNT andCTwere able to bind to BC1 (Fig.
2B, lanes 3 and 8). Binding of NT to BC1 RNA is specific and stoichio-
metric since complex formation can be competed by a 50-fold excess of
unlabeled BC1 RNA but not by nonspecific competitors (tRNAs) at the
same molar excess (Fig. 2C, compare lane 3with lane 4). Moreover, the
addition of lithium, a chaotropic agent that destabilizes nonspecific
binding, to the EMSA binding buffer, does not modify the strength of
BC1-NT interaction (Fig. 2C, compare lane 2with 5). In contrast, bind-
ing of CT is nonspecific; the complex appears as a smear rather than a
defined band on the EMSA gel, and both the tRNA competitor and
lithium are able to dissociate BC1 from the FMRPCT (Fig. 2C, compare
lanes 6 to 8 and 9). This nonspecific binding could be due to electrostatic
interactions with the RGG region, a cluster rich in arginines. The Kdapp
of the BC1-N terminus complex is 260 nM (Fig. 2D). This value was,
within experimental error, in excellent agreementwith that obtained for
the full-length protein, indicating that the NT gives themajor contribu-
tion to the FMRP-BC1 interaction, whereas other regions of FMRP
could give additional contributions to stabilize this binding. Two
shorter versions of NT, namedNDF-(1–134) andNDF/NLS-(1–180) in
Fig. 2A, are not able to bind to BC1 RNA. Therefore, the fragment
including the amino acids 180–217 and containing the putative helix-
turn-helix motif was essential for binding. Attempts to produce this
isolated region were, however, impaired by its tendency to aggregate
and to go into inclusion bodies. This suggested that the region of FMRP
comprising residues 180–217 is unable to fold independently of the
flanking regions.
The potential BC1 analog in primates is called BC200 RNA (29).
Distribution of the human BC200 RNA reveals neuron-specific expres-
sion and dendritic localization comparable with BC1 (36). Recently, we
demonstrated that BC200 RNA is able to form a complex with FMRP in
human neuroblastoma and glioma cell lines (7), suggesting that these
two BC RNAs have the same functional role in FMRP-dependent regu-
lation of translation. Moreover, BC200 RNA has also been shown to
bind the entire FMRP in vitro (Ref. 37 and data not shown). To see
whether BC200 is recognized in a manner similar to BC1, we also
checked the same FMRPdomains forBC200 binding (Fig. 3). As forBC1
RNA, only the entire NT of FMRP is able to bind to BC200 RNA (Fig. 3,
lane 2), and the apparent Kd is similar (300 nM), within experimental
FIGURE 1. BC1 RNA binds specifically andwith high affinity to FMRP. A, EMSA exper-
iments were performed incubating the 32P-labeled BC1 RNA (0.02 pmol) with (lane 2) or
without (lane 1) purified FMRP (6 pmol). The formation of RNA-protein complexes was
analyzed on native polyacrylamide gels. The position of the band corresponding to the
BC1-FMRP complex is marked by an arrow. Lanes 3 and 4 represent competition experi-
ments performed with a 50-fold excess of non-labeled BC1c (BC1 competitor) and total
yeast tRNAc (tRNA competitor). Reactions with bovine serum albumin (BSA) or with two
RNA-binding proteins, NusG and 15.5KD, are shown in lanes 5, 6, and 7, respectively. B, to
determine the BC1-FMRP Kdapp, increasing concentrations of FMRP protein (from lanes 2
to 10: 16, 30, 63, 94, 125, 156, 188, 219, and 250 nM)were used. Labeled BC1 RNA is shown
in lane 1. The arrow points to the band corresponding to the BC1-FMRP complex,
whereas the square brackets mark the free BC1. C, to estimate the Kdapp of BC1-FMRP
complex, [BC1]free values were plotted versus log [FMRP] as reported under “Experimen-
tal Procedures.”
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error, to the one observed for the BC1-NT complex (data not shown).
Thus, despite the considerable divergence of the two BC RNAs, FMRP
bound both through the same domain and with similar affinity.
The N-terminal Domain of FMRP Can Be Cross-linked Specifically to
BC1 RNA—Specific UV cross-linking at 254 nm between protein and
RNA in native or reconstituted protein-RNA complexes reflected effi-
cient binding between these two components, as it indicates that the
protein is in very close vicinity to certain bases of the RNA. We thus
investigated whether the NT of FMRP (aa 1–217) can be specifically
cross-linked to BC1 RNA.
Increasing amounts of FMRP NT were incubated with radioactively
labeled BC1 RNA prepared by transcription in vitro, and the mixture
was UV-irradiated at 254 nm. Subsequent analysis of the complexes on
a denaturing SDS-polyacrylamide gel revealed three labeled bands that
appear upon UV irradiation (Fig. 4A). Two of these bands (marked with
an asterisk) also appear with weaker intensity in UV-irradiated naked
BC1 RNA samples and are thus not considered to be protein-depend-
ent. The lowest, strongest band (XL), with an apparent molecular mass
of60 kDa, is obtained only from samples that contain both BC1 RNA
and FMRP protein. This particular band is also sensitive toward RNase
and proteinase K treatment (data not shown). We therefore concluded
that this band represents a cross-link between FMRP and BC1 RNA.
The specificity of the UV cross-link was verified by competition
experiments. For this purpose, FMRP NT-BC1 complexes were recon-
stituted and subsequently cross-linked in the presence of non-labeled
competitor RNAs, i.e. BC1 RNA and human U1 snRNA (Fig. 4B).
Although non-labeled BC1 RNA was able to compete with the binding
betweenNT and labeled BC1 RNA already at the lowest concentrations
tested, human U1 snRNA did not show any effect on the binding of
FMRPNT toBC1RNA.These results demonstrated unambiguously the
highly specific nature of the protein-RNA interaction between the N
terminus of the FMRP protein and the BC1 RNA.
FIGURE 2. TheN-terminal region of FMRPbinds specifically toBC1RNA.A, a schemeof the FMRP deletionmutants used in EMSA experiments. B, 32P-labeled BC1 RNA (0.02 pmol)
was incubated with 6 pmol each of the full-length FMRP (lane 2) or the FMRP domains (lanes 3–8), and the complexes were analyzed as above. Free BC1 RNA is shown in lane 1. The
positions of BC1-FMRP and BC1-NT complexes are indicated by arrows, free BC1 RNA ismarked by a square bracket, and the smear corresponding to BC1-CT complex is indicatedwith
an asterisk. C, competition experiments to determine the specificity of BC1-NT and BC1-CT interactions were performed with a 50-fold excess of non-labeled BC1 RNA (BC1c, lanes 3
and 7, respectively) or total yeast tRNA (tRNA competitor, lanes 4 and 8, respectively) or in the presence of Li ions (lanes 5 and 9, respectively). BC1 RNA alone is shown in lane 1,
whereas the complex BC1-NT or BC1-CT is shown in lanes 2 and 6, respectively.D, the plot represents the quantification of a titration experiment performed by incubating 0.02 pmol
of 32P-labeled BC1 RNA with increased concentrations of protein (17, 33, 67, 133, 267, and 533 nM). The Kdapp was determined as reported under “Experimental Procedures.”
FIGURE 3. BC200 RNA binds directly and specifically to N terminus of FMRP. Band
shift experiments were performed incubating the 32P-labeled BC200 RNA (0.02 pmol) in
thepresenceof four FMRPRNA-bindingdomains (N terminus, C terminus, KH1, andKH2).
A retarded band is shown (arrow) only for the BC200-N terminus complex (lane 2).
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FMRP Recognizes the 5 Stem Loop of BC1 RNA—To determine
which domain ofBC1RNAwas responsible for FMRPN terminus bind-
ing, an excess of unlabeled RNA constructs representing parts of the
BC1 RNA (Fig. 5A; 1–3) was used to compete for the interaction
with labeled BC1 RNA (Fig. 5B). These BC1 RNA constructs are
most likely structured in vitro, as suggested by the highly negative
G value of putative secondary structures (data not shown). Com-
plex formation (Fig. 5B, arrow) was completely inhibited by compe-
tition with a 50-fold excess of unlabeled full-length BC1 RNA (Fig.
5B, lane 3) and by competition with a 50–100-fold excess of 1
construct corresponding to the 5 stem loop (lanes 5 and 6), whereas
only weak reduction was observed by competition with a 100-fold
excess of the 3 construct (lane 12). No competition occurred with
the 2 construct corresponding to 3 stem loop. These data indi-
cated that FMRP contacts principally the 5 end of BC1. The 3
construct encompassing the A-rich stretch and a few nucleotides of
the 3 stem loop gave only a minor contribution, and the 3 hairpin
(construct 2) does not bind. The same experiment was repeated
with the full-length FMRP, and also, in this case, only the 1 con-
struct was able to compete with BC1 full-length (data not shown),
strengthening the idea that the 5 stem loop of BC1 is recognized by
FMRP. To further restrict the BC1 5 stem loop region involved in
the binding to FMRP NT, we made smaller constructs (named 4
and 5 in Fig. 5A) lacking the distal one-third of the 5 stem loop (nt
26–49) or the distal two-thirds of the 5 stem loop (nt 15–60) (see
“Experimental Procedures” for details). As shown in Fig. 5C, the
progressive deletion of the distal part of 5 stem loop leads to a
decrease of the interaction strength with the NT; although the con-
struct 4 is bound only weakly, the proximal part of 5 stem loop
alone (construct 5) does not bind the NT any longer. These data
altogether demonstrated that the integrity of 5 stem loop is required
for optimal binding between FMRP and BC1.
DISCUSSION
FMRP is known to contain several independent RNA-bindingmotifs;
besides the two well characterized KH domains, FMRP has at least two
other regions, including the N and C termini, with affinity for RNA (27,
38). Such amultiple RNA-binding platformmay determine whether the
FMRP-RNP complex participates in nuclear processes, nucleo-cyto-
plasmic shuttling, dendritic/axonal mRNA transport, or translational
control at different stages of development and cell cycle. Here, we have
demonstrated that the N terminus of FMRP contains a novel RNA-
bindingmotif that binds specifically to the rodentBC1 and to its primate
analog BC200 RNAs. Although binding of this region to RNA
homopolymers had been reported before (27), we have shown for the
first time that this isolated region is able to recognize the BC1 and
BC200 RNAs. The interaction seems highly specific since another non-
translatable RNAof a comparable length,U1RNA, is unable to bind. An
unspecific interaction due to double strand recognition could also be
ruled out because both U1 and a fragment of BC1 with a double
stranded structure do not bind.
We have demonstrated that NT is the region of FMRP necessary
and sufficient for BC1/BC200 RNA binding; no other regions of the
protein are able to recognize BC1 on their own, whereas the Kd
values obtained for the full-length protein and for the NT construct
were comparable. Further mapping of the interaction within the
FMRP NT showed that the region aa 180–217 is necessary for the
binding. The two deletion mutants of NT, NDF and NDF/NLS, are in
FIGURE 4.TheN-terminal domain canbe specifically cross-linked toBC1RNA.A, cross-linking of increasing amounts of theN-terminal domain of FMRP to in vitro-transcribed BC1
RNA. Lane 1, non-UV-irradiated BC1 RNA; lane 2, UV-irradiated BC1 RNA; lane 3, non-UV-irradiated in vitro reconstituted BC1 RNA-NT complex; lanes 4–9, UV-irradiated in vitro
reconstituted BC1 RNA-NT complex. For in vitro reconstitution of the BC1 RNA-NT complex, an increasing amount of the N-terminal domain of FMRP (1.5, 3.0, 7.5, 15, 30, and 75 pmol,
respectively) was used. Positions of the BC1 RNA and of FMRP cross-linked to BC1 RNA (XL) are indicated on the right. Molecular sizemarkers (indicated byMW) are shown on the left.
Bandsmarkedwith anasterisk also appearwithweaker intensity inUV-irradiatednakedBC1RNAsamples (Fig. 1B, lane 2) andare thusnot considered tobe strictly protein-dependent.
B, UV cross-linking of the N-terminal domain of FMRP to neuronal BC1 RNA in the presence of non-labeled competitor RNAs (neuronal BC1 RNA and human U1 snRNA). For the
competition experiment and for the control, lane 4, the BC1-NT complex was formed by incubating 150 fmol of BC1 RNA with 75 pmol of FMRP NT. Lanes 1–3, control lanes, as
described for panel A; lane 4, UV-irradiated in vitro reconstituted BC1 RNA-NT complex; lanes 5–9, UV cross-linking of in vitro reconstituted BC1 RNA-NT complexes formed in the
presence of increasing amounts of non-labeled BC1 RNA (1.5, 3.0, 7.5, 15 and 30 pmol, respectively); lanes 10–14, UV cross-linking of in vitro reconstituted BC1 RNA-NT complexes
formed in the presence of increasing amounts of non-labeled human U1 snRNA (1.5, 3.0, 7.5, 15, and 30 pmol, respectively). For further details, see the description of panel A.
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fact unable to bind BC1, thus suggesting that the BC1-binding motif
comprises the stretch between the NLS and KH1 (Fig. 2A). A struc-
tural characterization of NT had suggested that it contains at least
two distinct regions (28): the NDF and a potential helix-loop-helix
motif present in amino acids 181–214, the region that we now
observe to bind BC1. The structure of NDF has recently been solved
and contains two repeats of a Tudor domain fold,4 a motif known to
be involved in protein-protein interactions and in recognition of methy-
lated amino acids (40). Interestingly,NDF is highly flexible and presumably
needs other regions of FMRP or other partners to be stabilized. We can
therefore envisage that the structure containing the helix-loop-helix motif
(aa 180–217), which cannot be produced independently in a soluble form,
is determinedby its interactionswithNDF.TheRNA-binding site could be
highly localized in the region 180–217 or distributed along the whole NT
sequence, possibly making use of the several conserved positively charged
residues.
NT also encompasses the NLS, suggesting a role of the complex with
BC1 in the regulation of the FMRP cycle in and out of the nucleus.
Binding of BC1/BC200 RNA to FMRP could in fact mask this signal,
thus preventing import of the protein in the nucleus (10, 41–43),
whereas the disassembly of the FMRP-BC1 complex would make the
protein free to enter the nucleus again. Data reported here suggested
again that a protein with different RNA-binding domains may have
multiple roles. The fact that BC1 binds to the N-terminal portion of
FMRP leaves the other three RNA-binding domains available for further
recognition of additional targets. Therefore, FMRP can bind an mRNA
simultaneously through BC1 and a G quartet (Fig. 6), and the resulting
cooperativity would considerably strengthen the interaction with the
mRNA. In support of this notion, strong FMRP targets such as the
MAP1B and FMR1 mRNAs (7, 13, 14) contain both a G quartet and a
region complementary toBC1RNA. In addition, other points of contact
4 A. Ramos, D. Hollingworth, S. Adinolfi, M. Castets, G. Kelly, T. A. Frenkiel, B. Bardoni, and
A Pastore, submitted for publication.
FIGURE 5.The5 stem loopofBC1RNAbinds to FMRP-NT.A, schemeof the BC1deletionmutants used in the EMSAexperiments reportedbelow.1, nt 1–76 (corresponding to the
entire 5 stem loop);2, nt 127–152 (corresponding to theentire 3 stem loop);3, nt 61–138 (containing theAstretch);4, nt 1–25/50–76 (two-thirdsof 5 stem loop; thenucleotides
marked in redwere inserted tocreateaUUCGtetraloop);5, nt 1–14/61–76 (one-thirdof 5 stem loop).B, 50-foldexcessofunlabeledBC1RNA (lane3) or 10-, 50-, and100-foldexcesses
of each BC1 subregion corresponding to 0.2, 1, and 2 pmol, respectively (lane 4–12), were used as competitors in EMSA experiments. The mobility of labeled full-length BC1 or the
BC1-NT complex is shown in lanes 1 and 2, respectively. Only the entire BC1 RNA and the 5 stem loop are able to successfully compete with labeled BC1 for N terminus binding. The
positions of the BC1-NT complex and the free BC1 are indicated in the left by arrows. C, 32P-labeled, full-length BC1 RNA (lane 2) or deletionmutants of the 5 stem loop (1,4, and
5, lanes 4, 6, and 8, respectively) were incubatedwith theNT, and the complexeswere analyzed as in Figs. 2 and 3.The position of the BC1-NT (lane 2),1-NT (lane 4), and4-NT (lane
6) complexes is indicated on the right of each lane by a black dot. Free full-length BC1, 1, 4, or 5 RNAs, are shown in lanes 1, 3, 5, and 7, respectively.
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to further strengthen the FMRP-BC1-mRNA complex are possible; the
poly(A)-binding protein (PABP) associateswithBC1 (44), and those two
could interact with the poly(A) tail of the mRNAs (Fig. 6). The two KH
domains may recognize further, still uncharacterized, elements on the
mRNA. Recently, it has been proposed that the KH2 domain could bind
structured double stranded RNAs (45). Such a high synergy not only
makes binding stronger, it can also render mRNA recognition more
flexible; lack of one binding element can be compensated by a high
affinity version of another element.
On the BC1 side, we mapped the binding to the 5 stem loop, with a
minor contribution from the adjacent A-rich stretch. Binding occurred
to the upper part of this stem loop, as deletion of the top third severely
reduced binding, whereas deletion of the top two-thirds completely
abolished binding. The 5 stem loop of BC1 has been implicated in
several functions; first, this is the part of BC1 that exhibits complemen-
tarities to mRNAs targeted by FMRP (7). We envisage a role for FMRP
in mediating recognition/annealing between BC1 and the FMRP target
mRNAs as presented in Fig. 6. In agreement with this model, it has
recently been shown in vitro that FMRP has nucleic acid chaperone
properties (37), i.e. that it is able to catalyze RNA-RNA recognition and
annealing. The BC1/mRNA duplex that results from the chaperon
activity of FMRP is still bound by FMRP (Fig. 6). This hypothesis is
supported by the fact that all three components have to be present to get
a strong FMRP-mRNA interaction (7). The fact that FMRP recognizes
both the BC1 5 stem loop and the mRNA as well as the BC1/mRNA
duplex can be explained with a separation of the two binding sites on
BC1; the elements that are complementary tomRNAs are located in the
bottom two-thirds of the stem loop (7), whereas FMRP recognizes the
upper part (see above). However, the two elements could also overlap;
annealing of BC1 to an mRNA, rather than to itself, may create a struc-
ture that looks similar to the BC1 stem loop.
Moreover, the 5 BC1 segment (the first 62 nt) also contains a cis-
acting dendritic targeting element that determines the specific trans-
port of this RNA to dendrites (46).Most likely, this function is intimately
linked to themRNAannealing andFMRPbinding roles of the same region.
We envision a complex in which BC1 determines the specificity of FMRP
action andmaintains the regulatedmRNAs in an inactive status. This com-
plex will probably also be part of the translationally repressed transport
granules recently described along the dendrites (39).
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